|
|
BECC438s |
|
Vaxjo ID |
124 |
|
Vaccine Adjuvant Name |
BECC438s |
|
Adjuvant VO ID |
VO_0005297
|
|
Description |
Synthetic derivative of natural compound with TLR4 receptor that induces Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
US (University of Maryland, Baltimore) |
|
Host Species for Testing |
Mouse |
|
Function |
Type: TLR agonist vaccine adjuvant. Target Receptor: Toll-like receptor 4. Induces Th1/Th2 mixed immune profile LR agonist |
| References |
(Ernst, 2021): Vaccine Adjuvant Compendium (VAC) [https://vac.niaid.nih.gov/view?id=33]
|
|
